• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Kelun-Biotech

Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical, is a clinical-stage biotech company engaged in biologic therapeutics as well as small molecule discovery and development.

windmill turbines in the Netherlands
Biotech

Windward generates $200M with Novo Holdings, OrbiMed in tow

Novo Holdings-backed Windward is circling in $200 million and offering up to $970 million biobucks for rights to a clinical-stage antibody.
Gabrielle Masson Jan 10, 2025 10:02am
change direction new plan alter arrows move reprioritize

Merck bags one Kelun ADC for $37.5M, boots out another asset

Aug 20, 2024 6:43am
Merck

Merck trims mushrooming ADC pipeline by axing 2 Kelun programs

Oct 23, 2023 9:00am
cash

Synaffix, MacroGenics crack open ADC pact, tack on $2.2B to deal

Mar 14, 2023 10:30am
war chest treasure chest gold money cash box

Merck signs eye-popping $9.3B biobucks deal with Kelun-Biotech

Dec 22, 2022 9:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings